Biomarker ID | 1330 |
PMID | 24494028 |
Year | 2014 |
Biomarker | TP53INP2 |
Biomarker Basis | Expression Based |
Biomolecule | Protein |
Source | Urine |
Subjects | Humans |
Regulation | Differentially Expressed |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways include: CDK18 human kinase ARCHS4 coexpression, NRBP2 human kinase ARCHS4 coexpression, STK39 human kinase ARCHS4 coexpression, ACVR1B human kinase ARCHS4 coexpression, AATK human kinase ARCHS4 coexpression |
Experiment | Prostate Cancer Vs Benign Prostatic Hyperplasia |
Type of Biomarker | Diagnostic |
Cohort | 8 PCa patients, 12 BPH patients and 10 healthy males were selected for analysis |
Senstivity | 76% |
Specificity | 7% |
AUC | NA |
Accuracy | NA |
Level Of Significance | NA |
Method Used | qRT-PCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | NA |